NEW YORK (TheStreet) -- CHANGE IN RATINGS
Chase (CCF) downgraded to hold at TheStreet Ratings.
Chesapeake Energy (CHK) downgraded at Bernstein from Outperform to Market Perform, Bernstein Research said. $21 price target. Company lacks near-term catalysts.
Majesco Entertainment (COOL) downgraded to hold at TheStreet Ratings.E*Trade (ETFC) upgraded at BGB from Sell to Hold, BGB Securities said. Valuation call, based on a $7.50 price target. Fortinet (FTNT) upgraded at UBS to Buy from Neutral, UBS said. $28 price target. Upside to street estimates on increasing market share. Genon Energy (GEN) upgraded at UBS to Neutral from Sell, UBS said. $1.50 price target. Shares fairly valued. Hill-Rom (HRC) upgraded at BofA/Merrill from Underperform to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $34 price target. Johnson & Johnson (JNJ) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. $74 price target. McDonald's (MCD) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. $92 price target. Company faces multiple growth headwinds. Navistar (NAV) upgraded at JP Morgan from Underweight to Neutral, JP Morgan said. Risk/reward is more balanced at current levels. Petrologistics (PDH) rated new Buy at UBS. $16.50 price target. Propylene price dip and stock weakness gives a good buying opportunity. PetSmart (PETM) rated new Overweight at Morgan Stanley. $75 price target. Company can deliver stable growth and gain market share. Power Integrations (POWI) downgraded at Sterne Agee from Buy to Neutral, Sterne Agee said. Company will likely face weaker customer demand. $43 price target. UnitedHealth (UNH) rated new Overweight at JP Morgan. $72 price target. Company remains a core holding, despite industry regulatory risks. Woodward (WWD) rated new Buy at Keybanc. $45 price target. Company is leveraged to late-cycle secular growth.
STOCK COMMENTS / EPS CHANGESBiogen Idec (BIIB) target raised at Oppenheimer to $145. Analyst day highlights pipeline strength. Outperform rating. CNO Financial (CNO) added to Conviction Buy List at Goldman. Company can grow faster than its life insurance peers. Buy rating and $9 price target. Forest Laboratories (FRX) estimates cut at Morgan Stanley through 2014, Morgan Stanley said. Company lowered its guidance. $35 price target. Great Plains Energy (GXP) added to Top Picks Live! at Citigroup. $23 price target. Valuation gap should narrow as rates come closer to fruition and regulatory concerns diminish. Hershey (HSY) added to Conviction Buy List at Goldman. Company can deliver above-average sales and earnings growth. $76 price target. JPMorgan Chase (JPM) target lowered at Oppenheimer to $56. Contraction of market multiple. Outperform rating. Mastercard (MA) numbers lowered at Jefferies. Shares of MA now seen reaching $507, Jefferies said. Estimates also lowered on FX and macro risks. Buy rating. Altria (MO) target raised at Morgan Stanley to $30, according to Morgan Stanley. There's room for industry price increases in the U.S. Scotts Miracle-Gro (SMG) numbers cut at BofA/Merrill. Shares of SMG now seen reaching $39, according to Bank of America/Merrill Lynch. Estimates also reduced, given the company's new guidance. Underperform rating. AT&T (T) target raised at Jefferies to $36, Jefferies said. Divestiture of Advertising Solutions should help value gap close. Hold rating. >To submit a news tip, email: email@example.com.
Follow TheStreet on Twitter and become a fan on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV